Importance of Antibodies to Lipopolysaccharide in Natural and Vaccine-Induced Serum Bactericidal Activity against Neisseria meningitidis Group B

A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression

(2011) P.B. Keiser et al.   VACCINE

Mucosal Immunization with Vibrio cholerae Outer Membrane Vesicles Provides Maternal Protection Mediated by Antilipopolysaccharide Antibodies That Inhibit Bacterial Motility

(2010) A. L. Bishop et al.   INFECTION AND IMMUNITY

Genetic and Structural Characterization of L11 Lipooligosaccharide fromNeisseria meningitidisSerogroup A Strains

(2010) Noëlle Mistretta et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine

(2010) Wendell D. Zollinger et al.   VACCINE

Characterization of an Antibody Depletion Assay for Analysis of Bactericidal Antibody Specificity

(2009) W. D. Zollinger et al.   Clinical and Vaccine Immunology

Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal Response

(2009) V. Weynants et al.   INFECTION AND IMMUNITY

The structure of the L9 immunotype lipooligosaccharide from Neisseria meningitidis NMA Z2491

(2008) Biswa Choudhury et al.   CARBOHYDRATE RESEARCH

Vaccine-Induced Opsonophagocytic Immunity to Neisseria meningitidis Group B

(2008) J. S. Plested et al.   Clinical and Vaccine Immunology

Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures

(2008) Anne Jäkel et al.   VACCINE